Sage Therapeutics (NASDAQ:SAGE) traded lower for the third straight session on Tuesday after Bank of America moved the ...
As Sage Therapeutics Inc. contemplates its path forward after rejecting a buyout offer from Biogen, its top executive ...
Sage Group reports strong growth in Q4'24 and Q1'25, driven by Sage Intacct and AI innovation. Read why SGGEF stock is a Hold ...
Hosted on MSN1mon
Sage stock price target cut to $12 by H.C. WainwrightTsao's report followed Sage's announcement of a weaker-than-expected sales performance for the fourth quarter. The company's collaboration revenue from Zurzuvae was $11.4 million, a slight ...
Sage Group PLC closed 11.42% below its 52-week high of £13.49, which the company achieved on February 6th.
NEW YORK, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
The Sage Group plc (LON:SGE – Get Free Report)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,169.95 ($15.06) and ...
Bank of America started coverage on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a report released on Tuesday. The brokerage issued an underperform rating and a $5.00 target price on the ...
The concepts Harris outlined in conversation with Jon Reed at the Sage Transform conference almost a year ago are now taking shape. The company has a long history of investing in AI, and is taking the ...
Sage Copilot, which was officially rolled out last year, acts as a coordinator between the deep learning-based AI models the company has long relied on for specific individual tasks, allowing for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results